Date: 2012-07-25
Type of information: Production agreement
Compound: manufacturing and development services for a therapeutic vaccine product.
Company: Ark Therapeutics (UK) undisclosed leading European gene therapy company
Therapeutic area: undisclosed
Type agreement: manufacturing
production
Action mechanism:
Disease: undisclosed
Details: Ark Therapeutics has signed a master manufacturing services agreement with one of Europe\'s leading gene therapy companies. The partnership will initially cover Ark\'s supply of manufacturing and development services in respect of the partner\'s therapeutic vaccine product.
Financial terms: Financial details of the agreement were not disclosed.
Latest news:
